Diffuse cutaneous eruption due to interferon alfa and ribavirin treatment of chronic hepatitis C [13]

Journal of the European Academy of Dermatology and Venereology

Volumn 19, Issue 3, 2005, Pages 396-398

  Şavk, Ekin ^a   Uslu, G ^a   Karaoglu A O ^a   Sendur N ^a   Karaman, G ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIHISTAMINIC AGENT; CORTICOSTEROID; RIBAVIRIN;

ADULT; CASE REPORT; CLINICAL EXAMINATION; DISEASE COURSE; DRUG WITHDRAWAL; HEPATITIS C; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; LABORATORY TEST; LETTER; MALE; OUTCOMES RESEARCH; PATCH TEST; PRIORITY JOURNAL; PRURITUS; SKIN BIOPSY; SKIN MANIFESTATION;

ANTIVIRAL AGENTS; DRUG ERUPTIONS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; RIBAVIRIN;

EID: 18844407502     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2004.01143.x     Document Type: Letter

References (6)

1. Sparsa A, Loustaud-Ratti V, Liozon E et al. Cutaneous reactions or necrosis from interferon alpha: Can interferon be reintroduced after healing? Six case reports. Rev Med Intern 2000; 21(9): 756-763.
2. Dalekos GN, Christodoulou D, Kistis KG et al. A prospective evaluation of dermatological side-effects during alpha-interferon therapy for chronic viral hepatitis. Eur J Gastroenterol Hepatol 1998; 10(11): 933-939.
3. Willems M, Munte K, Vrolijk JM et al. Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection. Br J Dermatol 2003; 149(2): 390-394.
4. Stryjek-Kaminska D, Ochsendorf F, Roder C et al. Photoallergic skin reaction to ribavirin. Am J Gastroenterol 1999; 94(6): 1686-1688.
5. Dereure O, Raison-Peyron N, Larrey D et al. Diffuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C: a series of 20 patients. Br J Dermatol 2002; 147(6): 1142-1146.
6. Toyofuku K, Imayama S, Yasumoto S et al. Clinical and immunohistochemical studies of skin eruptions: relationship to administration of interferon-alpha. J Dermatol 1994; 21(10): 732-737.